**Core tip:** One of the main goals of colonoscopy screening is to identify polypoid lesions, which are precursors of colorectal cancer. Once identified, the polypoid lesions need to be removed whenever possible. Throughout the years, many prototypes of colonoscopes, magnification techniques, and different devices such as caps have been developed for colonoscopy screening. Endocuff is a new device used to improve adenoma detection rates during colonoscopy. Based on the findings of many studies, Endocuff seems to be of great help in increasing the detection of colonic polyps, with no significant complications associated with its use.

INTRODUCTION
============

Colorectal cancer (CRC) is one of the most frequently observed cancers, and screening programs, including the adenoma detection rate (ADR), play an important role in reducing its incidence. There are many screening methods such as withdrawal time and technique, second evaluation of the right colon, patient positional changes, gastrointestinal assistant participation during colonoscopy, water-aided technique, optimisation of bowel preparation, and antispasmodic administration\[[@B1]\].

Colonoscopy is globally recognised as the gold standard for CRC screening. A widely used indicator to emphasise "good colonoscopy" is the ADR, which refers to the number of patients out of every 100 undergoing first-time colonoscopy who have at least one adenoma removed\[[@B2]\]. Several studies showed that the prevalence of adenomas in asymptomatic adults vary from 25% to 40%\[[@B3]-[@B6]\]. Based on these findings, in 2014, a joint task force of the American College of Gastroenterology and the American Society of Gastrointestinal Endoscopy recommended an ADR benchmark of 25% for all patients (30% for men and 20% for women)\[[@B7]\]. ADR has been considered as the major quality measure predicting subsequent CRC incidence and mortality\[[@B8]\].

Over the years, several accessories have been developed in order to obtain a more accurate visualisation of the colon, facilitating and increasing the identification of polypoid lesions. Recently, one such new device called Endocuff has been developed.

The aim of this review is to identify the studies comparing Endocuff-assisted colonoscopy to standard colonoscopy considering the ADR as the end-point by searching through MEDLINE/PubMed and abstracts presented at international meetings, from January 2014 until January 2017. In particular, the following key-words were searched: "adenoma detection rate", "Endocuff" and "Endocuff-assisted colonoscopy".

TECHNICAL CHARACTERISTICS, METHODS OF USE AND INDICATIONS
=========================================================

The Endocuff™ Vision (ARC Medical Design and Norgine) is a new device created with the intent to improve the endoscopic view. It is a soft plastic cap of 2 cm in length, consisting of a cylindrical core in propylene endowed with small flexible finger-like projections made of a thermoplastic elastomer fixed to the core\[[@B9],[@B10]\]. The first version of Endocuff™, dated in 2012 with the Food and Drug Administration approval, presented one proximal and one distal row of finger-like projections. On the contrary, the latest version, named Endocuff Vision™, has only one proximal row of more rounded finger-like projections in order to eliminate mucosal lacerations that were observed in the first model\[[@B11]\] (Figure [1](#F1){ref-type="fig"}). This device presents different colour-coded sizes (blue, green, purple, and orange) depending on the various colonoscopy compatible, both for paediatric than for adults instruments.

![Endocuff's view: (A) lateral; (B) from above.](WJCC-5-258-g001){#F1}

The device is for single use and is not recyclable. The usage is very simple, as it uses the distal end of the endoscope (Figure [2](#F2){ref-type="fig"}), which virtually coincides with the end of the tip of the colonoscope. Here, lubricants are not used due to their high risk of displacement from the scope during the procedure.

![Endocuff Vision™ mounted at the tip of the colonoscope.](WJCC-5-258-g002){#F2}

There are two principal indications for use: (1) keeping the suitable depth of endoscope\'s view field; and (2) helping the endoscope with being inserted into the gastrointestinal tract. During colon intubation, this accessory is practically invisible, and the projections do not interfere with the introduction. On the contrary, during the tool retraction, this device flattens folds, in particular of the sigmoid colon, and flexures of bowels (Figure [3](#F3){ref-type="fig"}).

![Endoscopic view of colonoscope retraction in which it's possible to note the flatting folds.](WJCC-5-258-g003){#F3}

Pioche et al\[[@B12]\] conducted a simulated pilot study which included an animal colorectal model used for learning and 32 endoscopists as follows, 16 Japanese and 16 visitors, in order to verify the Endocuoff's effectiveness in identifying the polypoid lesions. The model was specifically designed with the "packaging" of 13 polyps located in various locations, including those behind the folds. Endoscopists had a different degree of experience and worked randomly, either by performing standard colonoscopies (SC) or Endocuff-assisted colonoscopy (EAC). Their results showed that EAC detected more polyps compared to SC (mean lesions: 9.9 *vs* 7.5, *P* = 0.03) and that the use of this device was independent of the various endoscopic medical expertise levels\[[@B12]\].

CONTRAINDICATIONS
=================

Reported contraindications in the usage of Endocuff Vision™ are: (1) known colonic strictures; and (2) active inflammatory disorders (acute infective colitis, colonic Crohn's disease, ulcerative colitis, and acute diverticulitis)\[[@B11]\]. Moreover, this device was not designed with the objective of deep ileal intubation, and it is strongly discouraged for complex sub-mucosal dissection (such as ESD, Endoscopic Submucosal resection).

ANALYSIS OF STUDIES AVAILABLE IN THE LITERATURE
===============================================

The first report on the use of this accessory was published in 2012 by Sanders and Tsiamoulos et al\[[@B9]\] of St Mark's Hospital in London. This was a single-centre, retrospective study with a small number of cases. The authors reported their experience with endoscopic cuff-assisted endoscopic mucosal resection (EMR) (5 patients) and control post scars-EMR (7 patients) for large flat/sessile sigmoid colon polyps. All the lesions were located in the sigmoid sigma, and no adverse events were seen.

Reviewed available studies focusing on EndoCuff-assisted colonoscopy are reported in Table [1](#T1){ref-type="table"}. It was excluded from the analysis of the data, an ongoing study, promoted by Bevan et al\[[@B11]\]. It is a is a prospective, multicenter, randomised controlled trial comparing the ADR in patients undergoing EAC with SC. This study will be held at seven hospitals and will include the enrolment of 1772 patients\[[@B11]\].

###### 

Studies focusing on EndoCuff-assisted colonoscopy

  **Ref**.                            **Year**   **No. of patients (EAC)**   **No.of patients (SC)**                        **Adenoma detection rate (%) (EAC)**   **Adenoma detection rate (%) (SC)**   **ADR significance**
  ----------------------------------- ---------- --------------------------- ---------------------------------------------- -------------------------------------- ------------------------------------- ----------------------
  Floer et al\[[@B14]\]               2014       238                         229                                            35.4                                   20.7                                  *P* \< 0.0001
  Lenze et al\[[@B15]\]               2014       50                          //                                             34                                     //                                    //
  Marsano et al\[[@B16]\]             2014       165                         153                                            46.6                                   30                                    *P* = 0.002
  Tsiamoulos et al\[[@B17]\]          2014       133                         133 (pre-cuff period) 133 (post-cuff period)   68.98                                  55.13 61.74                           //
  Sawatzki et al\[[@B18]\]            2015       104                         //                                             47                                     //                                    //
  Chin et al\[[@B19]\]                2015       93                          193                                            44.1                                   27.3                                  *P* = 0.01
  Van Doorn et al\[[@B20]\]           2015       530                         533                                            52                                     52                                    *P* = 0.92
  Biecker et al\[[@B10]\]             2015       245                         253                                            56                                     42                                    *P* = 0.001
  Cattau et al\[[@B21]\]              2015       329                         329                                            49.7                                   46.4                                  *P* = 0.392
  Shah-Ghassemzadeh et al\[[@B22]\]   2015       219                         230                                            62.1                                   49.13                                 *P* = 0.0057
  Bhattacharyya et al\[[@B23]\]       2016       266                         265                                            63                                     60.9                                  NS
  Cavallaro et al\[[@B24]\]           2016       445                         403                                            53                                     46                                    *P* \< 0.05
  De Palma et al\[[@B25]\]            2017       137                         137                                            26.9                                   26.3                                  *P* = 0.002

EAC: Endocuff-assisted colonoscopy; SC: Standard colonoscopy; NS: Not significant; ADR: Adenoma detection rate.

REPORTED COMPLICATIONS
======================

As observed in a recent meta-analysis\[[@B13]\], four studies\[[@B10],[@B14],[@B17],[@B20]\] reported complication rates in the EC groups. The most frequent complication was superficial mucosal injury of negligible clinical significance that was found in 27 patients. Patient discomfort resulted in the removal of the cap in 23 cases, following which it was possible to complete the procedure. Another common complication was the loss of the device during the examination of 6 patients. In all these cases, the accessory was removed, and the study was complete. No perforations were reported\[[@B13]\]. Tsiamoulos et al\[[@B17]\] described elective removal in 4 cases due to sigmoid diverticulitis and 1 due to anal discomfort. Cattau et al\[[@B21]\] signalled one loss of the cap and one incomplete examination due to advanced diverticulosis. De Palma et al\[[@B25]\] reported nine complications: 2 cases of device loss during the withdrawal and 7 cases of mucosal erosions, of which in 1 case was necessary sclerosis with adrenaline.

OUR INITIAL EXPERIENCE
======================

The regional program for the CRC screening is operating at our Hospital. After the adhesion of the population to faecal occult blood test (FOBT), colonoscopy is mandatory. Colonoscopies, all conducted until the cecum, were performed using Endocuff Vision™ by expert operators with conventional colonoscopes (CF-Q165L, CF-H1285L, Olympus Optical, Hamburg, Germany). The bowel preparations used were the standard large-volume polyethylene glycol electrolyte solutions prepared the previous day or the split-dose regimens, depending on the time of the examination. Thirty patients (F 18, M 12) with a mean age of 67 years (range: 50-75 years), who underwent first-time screening colonoscopy, were studied. A total of 45 polyps were removed, 36 sessile (80%) and 9 pedunculated (20%). The sigma was involved in nearly half of the cases (45.7%). During our initial experience, we found polypoid lesions localised especially in the sigmoid colon that could be easily removed (Figure [4](#F4){ref-type="fig"}). No major adverse events were recorded, except for two cases of superficial "scratch-like" mucosal lesions of no clinical significance that occurred in the case of rigid colon due to inflammation (mild diverticulitis).

![Endoscopic removal of a sessile polyp of the sigmoid colon, in which it's possible to see the Endocuff's flat (white arrow) and injection needle (22 G, Micro-Tech, Nanjing Co, Ltd) (black arrow).](WJCC-5-258-g004){#F4}

CONCLUSION
==========

Prompt diagnosis of precancerous polyps during colonoscopy is extremely important in order to reduce CRC rate, especially in asymptomatic patients. During colonoscopy, the rate of colonic polyps missed varies from 6% to 27%\[[@B26]\]. It is known that the most effective way to estimate the adenoma miss rate, and consequently improve the ADR, is represented by the "back-to-back colonoscopy" technique performed in two consecutive same-day procedures in the same patient\[[@B27]\]. However, we cannot ignore this may double the potential complications, such as the risk of perforation.

The first study of this method using EndoCuff has been conducted by De Palma et al\[[@B25]\] in a single-centre randomised back-to-back-study. The participants underwent two colonoscopies, with and without the use of the device. The authors concluded that these kinds of examinations allow finding lesions missed by other procedures, but on the other hand, a limitation raised being the endoscopists not blinded for the presence of Endocuff\[[@B25]\]. From these studies emerge that the use of transparent plastic caps attached to the tip of the colonoscope can increase the ADR, with a mechanical mechanism of flattening the folds and the consequent increase of the visual field. This technique is known as cap-assisted colonoscopy (CAC). However, several works show conflicting results with respect to improvement in adenoma detection by CAC. In particular, the ADR was not significantly improved in 6 studies analysed in a meta-analysis including 16 RCTs that compared CAC to standard colonoscopy\[[@B28]\].

As for the CAP, our results were not in agreement in defining the EAC superiority over SC. In fact, in three studies, there was no statistical significance between the two groups (EAC *vs* SC)\[[@B20],[@B21],[@B23]\]. As the Table [1](#T1){ref-type="table"} shows, this device can enhance the ADR.

The most frequently observed complication was the removal of Endocuff's due to the discomfort of the patient (24 times), followed by the loss of the device during the examination (9 times). No major complications were reported.

In Italy, CRC is one of the most frequently found cancers. At our local hospital, we started regional screening program for this kind of tumor from January 2012 onwards. In our country, the device has been registered in the database of medical devices of the Ministry of Health on January 29, 2016\[[@B29]\].

Our early experiences with EAC on a small population show that Endocuff can identify and facilitate polypectomy, especially in floppy folds of sigma, allowing better stabilization of endoscope in front of the polyp. Among 30 patients, we found 2 cases (6.6%) of insignificant superficial mucosal lacerations, probably related to the lack of experience with this accessory.

Some major limitations are represented by special circumstances such as sub-colonic strictures and acute inflammation of the mucosa (diverticulitis and inflammatory bowel diseases).

Unfortunately, when a person is subjected to colonoscopy for the first time, it is impossible to know any underlying diseases. Therefore, in some cases, it becomes necessary to remove the device in order to complete the procedure safely.

In conclusion, the results of EAC are still evolving. This accessory appears safe and useful in increasing the detection of the number of polyps and subsequently, the detection rate of adenomas. We recommend that Endocuff should be further investigated in other larger trials.

Conflict-of-interest statement: The authors declare no conflicts of interest.

Manuscript source: Invited manuscript

Specialty type: Medicine, research and experimental

Country of origin: Italy

Peer-review report classification

Grade A (Excellent): 0

Grade B (Very good): 0

Grade C (Good): C, C, C

Grade D (Fair): 0

Grade E (Poor): 0

Peer-review started: February 7, 2017

First decision: May 8, 2017

Article in press: May 31, 2017

P- Reviewer: Amiri M, Pellicano R, Vij M S- Editor: Ji FF L- Editor: A E- Editor: Wu HL

[^1]: Author contributions: Zippi M and Traversa G made substantial contribution to study conception and design; Hong W and Crispino P were involved in acquisition, analysis and interpretation of data; Zippi M and Traversa G were involved in drafting the article, revising it critically for important intellectual content and gave final approval of the version to be published.

    Correspondence to: Maddalena Zippi, MD, PhD, Unit of Gastroenterology and Digestive Endoscopy, Sandro Pertini Hospital, Via dei Monti Tiburtini 385, 00157 Rome, Italy. <maddalena.zippi@aslroma2.it>

    Telephone: +39-6-41433310 Fax: +39-6-41733847
